PATENT CLAIM ANALYSIS

Application Number: 15898989
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-12
Patent Classification: ["514", "004800"]

Abstract:
Methods for regulating multiple organs, multiple genes and multiple targets by using a polypeptide, wherein the polypeptide comprising the amino acid sequence of SEQ ID No.1 and/or homology thereof. The present polypeptide reveals the potency to regulate transcription of multiple genes and expression of multiple targets. Therefore, a composition having the polypeptide can be applied to regulate the expression of multiple targets in multiple organs of patients. Furthermore, the composition having the polypeptide can be applied in therapies of inflammation and inflammatory disorders, suppression of fatty liver disease progression, suppression of the diseases caused by fatty accumulation, prevention and therapy of muscular atrophy, and avoiding the complications of diabetes.

Claim (Index 5):
The method of  claim 1 , wherein the disease is fat liver.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 88.0
- Lexical Diversity: 1.92063
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14773167', '14201488', '10029206', '15660116', '11809905']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7087224263031824
- 35 USC 102 Novelty (BERT): 0.5284312980409248
- Combined Prediction Score: 0.6906933134769566
- Mean Citation Score: 196.187524
- Max Citation Score: 200.78096
- Similarity Product: 95.49076122349264

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test